Ignite Creation Date:
2025-12-24 @ 11:05 PM
Ignite Modification Date:
2026-01-01 @ 6:47 PM
Study NCT ID:
NCT03712969
Status:
COMPLETED
Last Update Posted:
2024-05-09
First Post:
2018-10-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Shenlingcao Oral Liquid for Patients With Stage II or IIIA NSCLC
Sponsor:
West China Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-05
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-04
Completion Date Type:
ACTUAL
First Submit Date:
2018-10-09
First Submit QC Date:
None
Study First Post Date:
2018-10-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-07
Last Update Post Date:
2024-05-09
Last Update Post Date Type:
ACTUAL